Sign In
Buy BDX
$170.66
+0.540 (+0.317%)
At Close: Aug 05, 2026
Can Sustained Product Demand Drive BDX Stock Before Q2 Earnings?
01:20pm, Monday, 28'th Apr 2025
The continued solid uptake of BD's products is expected to have driven fiscal second-quarter revenues despite transitory market dynamics.
Gear Up for Becton Dickinson (BDX) Q2 Earnings: Wall Street Estimates for Key Metrics
10:21am, Monday, 28'th Apr 2025
Besides Wall Street's top -and-bottom-line estimates for Becton Dickinson (BDX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared durin
Becton, Dickinson and Company: It's Wait And See For Me
01:17am, Sunday, 27'th Apr 2025
Becton, Dickinson and Company is a leading medical device firm specializing in medical supplies, devices, laboratory equipment, and diagnostic products. BDX operates in three segments: BD Medical, BD
2025 Dividend Kings: Weathering Tariff Volatility Better Than The Market
09:58am, Wednesday, 23'rd Apr 2025
The Dividend Kings are outperforming the S&P 500 in 2025 by 8.94%. Top performers include National Fuel & Gas (+28.88%), Consolidated Edison (+28.10%), and Middlesex Water Company (+21.00%). Promising
BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair
06:50am, Wednesday, 23'rd Apr 2025
Phasix™ ST Umbilical Hernia Patch Leverages Same Surgical Technique as Permanent Mesh Procedures FRANKLIN LAKES, N.J. , April 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BD
BD Stock Down Despite Monitoring Platform Launch to Boost Patient Care
12:30pm, Tuesday, 22'nd Apr 2025
BDX's AI-based advanced hemodynamic monitoring platform is likely to aid clinicians to address blood flow instability and pressure in critical situations and improve patient outcomes.
BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support
07:35am, Monday, 21'st Apr 2025
HemoSphere Alta™ Advanced Monitoring Platform with Predictive, Smart Algorithms Helps Clinicians Proactively Address Instability in Blood Flow and Pressure in Critical Situations FRANKLIN LAKES, N.J
DGI For The DIY: 2024 Dividend Portfolio Review
09:33pm, Thursday, 17'th Apr 2025
This portfolio focuses on generating a growing stream of dividend income by investing in companies that consistently increase dividends. I reinvest dividends into more shares of the companies I alread
BD Seeks Potential Buyers for Life Sciences Business Division
07:50am, Tuesday, 08'th Apr 2025
Becton Dickinson is in preliminary talks to divest its $21 billion Life Sciences unit, exploring multiple options with major medtech players and diagnostics firms.
BD to Announce Financial Results for its Second Quarter of Fiscal 2025
04:15pm, Thursday, 03'rd Apr 2025
FRANKLIN LAKES, N.J. , April 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio
Becton Dickinson in talks to divest life sciences unit, FT reports
12:28am, Tuesday, 01'st Apr 2025
Medical device maker Becton Dickinson has begun discussions to sell its life sciences division, valued at $21 billion, and is in talks with competitors such as Thermo Fisher Scientific and Danaher , t
Best Dividend Aristocrats For April 2025
04:07pm, Monday, 31'st Mar 2025
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Br
BD Named One of America's Most Innovative Companies by Fortune
06:50am, Monday, 31'st Mar 2025
FRANKLIN LAKES, N.J. , March 31, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2025 list of America's
Becton Dickinson Could Be Cure To Demand For Medtech Supplies, With Robust Pipeline
01:14pm, Sunday, 30'th Mar 2025
Becton Dickinson gets rating buy in my first coverage of this stock. Macro demand for medtech and surgical supplies could favor this globally diversified firm with an active portfolio and growth pipel
BD Names Gregory J. Hayes to Board of Directors
04:15pm, Thursday, 27'th Mar 2025
FRANKLIN LAKES, N.J. , March 27, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Gregory J.
